Get the Daily Brief
Latest Biotech News
Hatteras Venture Closes $200M Funds Amid Fundraising Challenges
In a challenging fundraising environment for venture capital, Hatteras Venture Partners successfully secured $200 million for two new funds targeting seed- and early-stage biotech companies. This...
FDA Approves Jazz Pharmaceuticals' Drug for Rare Brain Tumor
The US Food and Drug Administration has granted approval to a new therapy developed by Jazz Pharmaceuticals targeting a rare form of brain tumor. This regulatory milestone provides a novel...
Metabolic Inflammation Model Links to Adolescent Reproductive Dysfunction
Recent research uncovers a novel connection between metabolic inflammation in the hypothalamus and reproductive issues in teenagers. This new model highlights the role of neuroinflammatory...
Clinical Trial Shows Nab-Paclitaxel Combo Outperforms Gemcitabine in Biliary Cancer
A multicenter phase II clinical trial has demonstrated that a chemotherapy regimen combining nab-paclitaxel with cisplatin delivers superior efficacy compared to gemcitabine in treating advanced...
Blood Test Predicts Immunotherapy Success in Triple-Negative Breast Cancer
Researchers at Fudan University Shanghai Cancer Center have identified a novel blood biomarker capable of forecasting patient response to immunotherapy in triple-negative breast cancer (TNBC)....
NIH Awards $14.9M Grant for Innovative HIV Persistence Research
A multi-institutional team led by Weill Cornell Medicine received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases to pursue breakthrough strategies...
Large Language Models Transform Drug Development Pipeline
Cutting-edge artificial intelligence, particularly large language models (LLMs), are reshaping drug discovery and development processes. These advanced AI architectures accelerate molecule design,...
Platelets' Emerging Role in DNA Surveillance and Cancer Detection
New scientific insights reveal that platelets possess functions extending beyond traditional blood clotting, including active roles in detecting DNA damage and participating in cancer...
China’s Efficient Biotech Hub Challenges US Dominance
China’s biotechnology sector, particularly centered in Wuxi near Shanghai, is rapidly expanding its capabilities in drug development and manufacturing, focusing on cost reduction and speed rather...
Breakthrough Imaging Captures Human Embryo Implantation Real Time
Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital achieved the first real-time, 3D visualization of human embryo implantation. Using a synthetic uterine...
Hatteras Secures $200M Amid Biotech Fundraising Challenges
In a challenging fundraising environment for venture capital, Hatteras Venture Partners successfully closed two new funds totaling $200 million to invest in seed- and early-stage biotech...
FDA Approves Jazz Pharma’s Drug for Rare Brain Tumor
The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals' new treatment for a rare brain tumor, offering a novel therapeutic option for patients with limited alternatives. This...
New Insights into Immune Regulation Challenge Therapeutic Paradigms
Recent research reveals complex interactions between regulatory T cells (Tregs) and pro-inflammatory Th17 cells mediated by cytokines IL-2, TGF-β, and IL-6, uncovering paradoxical mechanisms in...
Phase II Trial Shows Nab-Paclitaxel Combo Beats Gemcitabine in Biliary Cancer
A multicenter randomized phase II study published in BMC Cancer demonstrated that nab-paclitaxel combined with cisplatin outperforms gemcitabine monotherapy in treating advanced biliary tract...
Made Scientific Unveils Expanded GMP Facility for Cell Therapy Manufacturing
Made Scientific inaugurated a new 60,000-square-foot GMP manufacturing and headquarters facility in Princeton, NJ, marking a $12 million investment to support clinical-to-commercial scale cell...
Innovative CUT&Tag Buffer Adjustment Enables Transcription Factor Profiling
Scientists at the University of Cologne developed 'DynaTag,' a refinement of the CUT&Tag assay that reduces salt concentration to capture transient transcription factor binding on DNA. This...
Kriya Therapeutics Raises $313M to Advance Gene Therapy Pipeline
Kriya Therapeutics, a gene therapy biotech with operations in North Carolina and California, secured $313 million in a recent funding round to accelerate its development of gene therapies...
FDA Signals Flexible Rare Disease Approval with Precigen Case
The FDA’s recent decision allowing Precigen to bypass certain accelerated approval and confirmatory trial requirements for a rare disease therapy signals potential shifts in regulatory...
Human embryo implantation: First 3D real-time capture
Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital have achieved the milestone of recording human embryo implantation live and in three dimensions for the...
FDA grants full approval to Precigen’s rare disease gene therapy
Precigen Inc. received swift and full FDA approval for its gene therapy Papzimeos (zopapogene imadenovec), designed to treat adults with recurrent respiratory papillomatosis, a rare cancer-like...